Education
About Us
Working with TipRanks
Follow Us
Actinium Pharmaceuticals (ATNM)
:ATNM
ATNM Analyst Ratings
Strong Buy
3 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ATNM Stock 12 Month Forecast
Average Price Target
$6.00
▲(217.46% Upside)
| Highest Price Target$9.00 | Average Price Target$6.00 | Lowest Price Target$4.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
Reiterated
03/27/25
JonesTrading
Reiterated
03/26/25
Maxim Group
Reiterated
03/17/25
Stephens
$5
Buy
164.55%
Upside
Reiterated
11/19/24
Stephens reiterates Overweight Rating on Actinium Pharma (ATNM)Stephens analyst Sudan Loganathan reiterated an Overweight rating and $5.00 price target on Actinium Pharma (NYSE: ATNM).
B.Riley Financial
$16→$2
Hold
5.82%
Upside
Downgraded
08/07/24
Actinium Pharmaceuticals downgraded to Neutral from Buy at B. RileyActinium Pharmaceuticals downgraded to Neutral from Buy at B. Riley
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
03/27/25
JonesTrading
Reiterated
03/26/25
Maxim Group
Reiterated
03/17/25
Stephens
$5
Buy
164.55%
Upside
Reiterated
11/19/24
Stephens reiterates Overweight Rating on Actinium Pharma (ATNM)Stephens analyst Sudan Loganathan reiterated an Overweight rating and $5.00 price target on Actinium Pharma (NYSE: ATNM).
B.Riley Financial
$16→$2
Hold
5.82%
Upside
Downgraded
08/07/24
Actinium Pharmaceuticals downgraded to Neutral from Buy at B. RileyActinium Pharmaceuticals downgraded to Neutral from Buy at B. Riley
ATNM Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Nov 24
Jan 25
Mar 25
Strong Buy
13
7
7
7
13
Buy
0
1
1
1
0
Hold
0
1
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
9
9
9
13
Each month's total comprises the sum of three months' worth of ratings.
ATNM Financial Forecast
ATNM Stock Forecast FAQ
What is ATNM’s average 12-month price target, according to analysts?
Based on analyst ratings, Actinium Pharmaceuticals’s 12-month average price target is $6.00.
What is ATNM’s upside potential, based on the analysts’ average price target?
Actinium Pharmaceuticals has 217.46% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ATNM a Buy, Sell or Hold?
Actinium Pharmaceuticals has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Actinium Pharmaceuticals’s price target?
The average price target for Actinium Pharmaceuticals is $6.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $9.00 ,the lowest forecast is $4.00. The average price target represents 217.46% Increase from the current price of $1.89.
The highest analyst price target is $9.00 ,the lowest forecast is $4.00. The average price target represents 217.46% Increase from the current price of $1.89.
What do analysts say about Actinium Pharmaceuticals?
Actinium Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of ATNM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.